The litigation centers on claims that Nano-X failed to provide an accurate picture of its operational health during the specified period. According to the complaint, the company overstated demand for its products while simultaneously struggling with rising operating expenses and cash burn. These internal pressures culminated in a shift toward an outsourced production model and the restructuring of the firm’s Korean chip manufacturing facility.
Market confidence faltered on April 20, 2026, when Nano-X reported a $33.4 million net loss for the fourth quarter of 2025. This figure included a $17.5 million impairment charge tied to the restructuring of its long-lived assets. Following these disclosures and the announcement that the Chief Financial Officer would step down, Nano-X shares dropped approximately 24.39%, closing at $2.155 per share.
The law firm Robbins LLP is currently representing investors in the class action. Those who suffered financial losses have until August 11, 2026, to file for lead plaintiff status. Participation in the lawsuit does not require serving as a lead plaintiff, and the firm operates on a contingency fee basis, meaning shareholders are not responsible for upfront legal costs.
Comments (0)
No comments yet. Be the first!